The largest database of trusted experimental protocols

24 protocols using clindamycin

1

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility were studied by modified Kirby Bauer’s disc diffusion method on Mueller Hinton Agar plates (12 cm diameter) using ampicillin (10 μg), cotrimoxazole (1.25/23.75 μg), ciprofloxacin (5 μg), vancomycin (30 μg), cephalexin (30 μg) and gentamycin (10 μg) discs. Cefoxitin (30 μg) for the detection of methicillin resistance and erythromycin (15 μg), clindamycin (2 μg) discs (Hi-media-India) at 15 mm apart were also used on same plate for the detection of inducible clindamycin resistance as per CLSI guidelines [17 ].
+ Open protocol
+ Expand
2

Antimicrobial Susceptibility of MRSA Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro antimicrobial susceptibility test for all the MRSA isolates were performed using ampicillin (A), ampicillin/sulfbactam (A/S), chloramphenicol (CL), ciprofloxacin (CP), clindamycin (CD), co-trimoxazole (COT), levofloxacin (LE), linezolid (LZ), fusidic acid (FC), minocycline (MIN), mupirocin (MU), ofloxacin (OF), oxacillin (OX), gentamicin (G), tetracycline (TET), rifampicin (RIF), teicoplanin (TEI), and vancomycin (V) (HiMedia Laboratories, India). Minimal inhibitory concentration (MIC) of daptomycin and vancomycin were determined by E-test method (Biomerieux, New Delhi; Ezy MIC strips, HiMedia Laboratories, India). The MRSA isolate that exhibited a vancomycin MIC of 4-8 mg/L was considered a VISA isolate. All assays were performed in accordance with Clinical and Laboratory Standards Institute guidelines.[18 ]
+ Open protocol
+ Expand
3

Antibiotic Susceptibility of Common Bacterial Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six bacterial strains, Bacillus pumilus MTCC 1607, Streptococcus aureus MTCC 902, Escherichia coli MTCC 1304, Klebsiella pneumoniae MTCC 3384, Pseudomonas aeruginosa MTCC 741 and Salmonella typhi MTCC 537, were grown at 160 rpm in nutrient broth (NB) at 32 °C. Seventeen antibiotics discs named Amikacin (Ak) 30 µg, Ampicillin (A) 10 µg, Ampicillin/Sulbactam (Ams) 10/10 µg, Amoxyclav (Ac) 30 µg, Ceftazidime (Ca) 30 µg, Cephotaxime (Ce) 30 µg, Ciprofloxacin (Cf) 5 µg, Clindamycin (Cd) 2 µg, Co- Trimoxazole (Co) 25 µg, Erythromycin (E) 15 µg, Gentamycin (G) 10 µg, Nalidixic acid (Na) 30 µg, Netillin (Nt) 30 µg, Nitrofurantoin (Nf) 300 µg, Penicillin G (P) 10 units, Tobramycin (Tb) 10 µg and Vancomycin (Va) 3 µg, were procured from HiMedia Laboratories Pvt. Ltd., India.
+ Open protocol
+ Expand
4

Antimicrobial Susceptibility of S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the identified S. aureus isolates were subjected to an in vitro antimicrobial susceptibility test by employing the modified Kirby–Bauer disc diffusion method as recommended by Clinical and Laboratory Standard Institute (CLSI) guidelines [19 ]. The antimicrobial disks used were ampicillin (30 μg), cefoxitin (30 μg), chloramphenicol (30 μg), ciprofloxacin (25 μg), clindamycin (31 μg), cotrimoxazole (25 μg), erythromycin (26 μg), gentamycin (28 μg), linezolid (30 μg), oxacillin (10 μg), tetracycline (20 μg), and penicillin (10 μg) from HiMedia, India.
+ Open protocol
+ Expand
5

Antibiotic Susceptibility Testing of Isolated Organisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibiotic susceptibility tests of the isolated organisms were done using Mueller Hinton Agar (MHA) by the standard disk diffusion technique of the Kirby-Bauer method as recommended by CLSI [21 ]. The following antibiotics with specified concentrations were used: ampicillin (10 μg), ampicillin-sulbactam (10/10 μg), amoxycillin-clavulanic acid (20/10 μg), cefixime (5 μg), ceftazidime (30 μg), ceftriaxone (30 μg), cefepime (30 μg), cefoxitin (30 μg), piperacillin (100 μg), piperacillin-tazobactam (100/10 μg), cotrimoxazole (1.25/23.75 μg), gentamicin (10 μg), amikacin (30 μg), imipenem (10 μg), meropenem (10 μg), ciprofloxacin (5 μg), levofloxacin (5 μg), colistin sulfate (10 μg), erythromycin (15 μg), clindamycin (2 μg), vancomycin (30 μg), teicoplanin (30 μg), doxycycline (30 μg), and chloramphenicol (30 μg) from HiMedia Laboratories, India.
+ Open protocol
+ Expand
6

Bacteriological Analysis and Antibiotic Susceptibility

Check if the same lab product or an alternative is used in the 5 most similar protocols
The swabs collected were directly inoculated in duplicate on blood agar, (Oxoid) Mac Conkey agar and Muller Hinton agar (Oxoid). The pairs of inoculated media were incubated aerobically at 37 °C for 24 h and then examined for bacteria growth according to standard protocol [14 ]. The positive culture growths were examined for colony characteristics, Gram-reaction and biochemical characteristics as described by Cheesbrough (2000) [14 ]. The biochemical characteristics tested were: (i) catalase, (ii) coagulase, (iii) oxidase, (iv) hemolysis, (v) sugar fermentation, (vi) indole production, (vii) citrate utilization, (viii) urease activity, (ix) triple sugar iron and (x) hydrogen sulphide production.
Purified bacterial isolates were subjected to drug susceptibility tests using the Kirby Bauer disc diffusion method [14 ]. Commercially available antibiotic discs that were used include: ciprofloxacin, norfloxacin, gentamycin, erythromycin, clindamycin, cephalexin, co-trimoxazole, tetracycline, cefoxitin, ampicillin, vancomycin and chloramphenicol (Hi Media Laboratories Pvt. Ltd, India). These antibiotics were chosen based on the type of microorganisms frequently isolated and their availability at University Teaching Hospital.
+ Open protocol
+ Expand
7

MRSA Antimicrobial Susceptibility Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial susceptibility testing of MRSA was detected using
the modified Kirby-Bauer disk diffusion method according to the clinical
laboratory standard institute (CLSI) guidelines (CLSI 2013 ). The following antimicrobials were used in
their respective concentration: Ciprofloxacin (5 μg),
Trimethoprim-Sulfamethoxazole (1.25/23.75 μg), Erythromycin (15 μg), Clindamycin
(2 μg), and Amikacin (30 μg) (Hi-Media, India). These antimicrobials were selected
based on the local usage to treat MRSA and considering the recommended
antimicrobial agents for MRSA infections.
+ Open protocol
+ Expand
8

Antimicrobial Resistance Profiling of Clinical Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility tests of the clinical isolates against different antimicrobials were performed in Müller–Hinton agar (MHA) using the standard disk diffusion technique (modified Kirby–Bauer method) and interpreted as per Clinical and Laboratory Standards Institute guidelines.16 The following antimicrobial agents were tested: ampicillin (10 μg), cefoxitin (30 μg), ciprofloxacin (5 μg), chloramphenicol (30 μg), clindamycin (2 μg), cotrimoxazole (25 μg), doxycycline (30 μg), erythromycin (15 μg), gentamicin (10 μg), minocycline (30 μg), rifampicin (5 μg), teicoplanin (30 μg), tetracycline (30 μg) and vancomycin (30 μg) (HiMedia Laboratories, Mumbai, Maharashtra, India). S. aureus ATCC 25923 was used as the control organism.
Isolates were considered multidrug resistant (MDR) based on the guidelines recommended by the joint initiative of the European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC).17 (link) According to those guidelines, the isolates showing non-susceptibility to at least one agent in three or more antimicrobial categories were identified as MDR.
S. aureus isolates showing positive D zone test were considered as resistant to clindamycin.
+ Open protocol
+ Expand
9

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility testing was performed by the Kirby–Bauer disk-diffusion method on Mueller–Hinton agar supplemented with 5% sheep blood for the following antimicrobial agents: penicillin (10 U), ampicillin (10 µg), erythromycin (15 µg), clindamycin (2 µg), ofloxacin (5 µg), cefotaxime (30 µg), linezolid (30 µg), and vancomycin (30 µg) (HiMedia Laboratories, Mumbai). The inoculum for susceptibility testing and interpretation was performed as per the Clinical and Laboratory Standards Institute (CLSI) guidelines [14 ].
+ Open protocol
+ Expand
10

Evaluation of Antibacterial and Antifungal Activities

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibacterial activity was evaluated by the double micro-dilution method for the determination of minimum inhibitory (MIC) and bactericidal concentration (MBC) against six clinical bacterial strains and two Candida strains isolated from pregnant women with symptoms of vaginal infections according to the standard CLSI procedure and previously described methods [47 ,48 ]. Two Gram-positive (S. aureus MRSA, Enterococcus sp.) and four Gram-negative strains (Escherichia coli, Proteus mirabilis, Proteus vulgaris and Pseudomonas aeruginosa) were used to determine the antibacterial activity. The testing of antifungal activities was determined on C. albicans strains. Two laboratory strains were obtained from the Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, and four clinical isolates were obtained from the Faculty of Medicine, Clinical Center of Vojvodina, Department of Obstetrics and Gynecology, isolated during regular gynecological examination in women. Their use was approved by the Ethics Committee of the Faculty of Medicine. Microtiter plates were incubated in a thermostat for 24 h at 37 °C, and MIC and MBC were determined. The disk-diffusion method was applied for bacterial susceptibility of standard antibiotics (Himedia, Einhausen, Germany): erythromycin, clindamycin, ciprofloxacin, gentamicin, ofloxacin, chloramphenicol and levofloxacin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!